AFP Human

Alpha-Fetoprotein Human
Shipped with Ice Packs
In Stock

Description

Definition and Biological Role

Alpha-fetoprotein (AFP) is a 591-amino-acid glycoprotein with a carbohydrate moiety, structurally homologous to human serum albumin (HSA) . It is primarily synthesized by the fetal yolk sac and liver during gestation, functioning as a transport protein for fatty acids, metals (e.g., copper, zinc), and bilirubin . Postnatally, AFP production declines, reaching adult levels (<10 ng/mL) by 8–12 months of age . Elevated AFP in adults is linked to malignancies (e.g., hepatocellular carcinoma [HCC]) and developmental abnormalities .

Functional Insights

  • Ligand Binding: Preferentially binds polyunsaturated fatty acids (e.g., arachidonic acid) and metals like Zn²⁺, critical for nutrient transport in fetal development .

  • Immunomodulation: Suppresses T-cell responses and promotes tumor immune evasion in HCC .

  • Estrogen Binding in Rodents: Prevents maternal estrogen from virilizing female fetuses, though this mechanism is absent in humans .

Diagnostic and Prognostic Applications

ConditionAFP LevelClinical Utility
Hepatocellular Carcinoma>200 ng/mLDiagnostic marker; correlates with tumor burden
Germ Cell Tumors>1,000 ng/mLIndicates yolk sac components
Neural Tube DefectsElevated in amniotic fluidPrenatal screening
Chronic Liver DiseaseGradual increaseEarly HCC detection in high-risk patients

A retrospective study of 17 patients with AFP >300 ng/mL and negative MRI findings found 59% developed HCC within 41–247 days, underscoring AFP’s prognostic value .

Therapeutic Monitoring

  • AFP levels decline post-resection or chemotherapy if treatment is effective .

  • AFPep, a peptide derivative, shows experimental anti-cancer properties but remains under investigation .

Recent Research Advances

  • Cryo-EM Structural Analysis: Identified fatty acid binding in subdomains IIA and IIIA, highlighting AFP’s role in nutrient transport .

  • Drug Delivery Potential: AFP’s affinity for tumor-specific receptors (e.g., glypican-3) positions it as a candidate for targeted therapies .

  • Genetic Regulation: The AFP gene’s repression postnatally and reactivation in HCC involves enhancer elements shared with albumin, offering insights into oncogenic pathways .

Challenges and Future Directions

  • Specificity Limitations: Elevated AFP occurs in non-malignant conditions (e.g., chronic hepatitis), necessitating complementary biomarkers .

  • Glycosylation Variants: Lectin-binding assays (e.g., Lens culinaris agglutinin) improve diagnostic specificity for HCC .

  • Therapeutic Targeting: Ongoing studies explore AFP-neutralizing antibodies and AFP-drug conjugates .

Product Specs

Introduction
Alpha-fetoprotein (AFP) is typically produced in the liver, intestines, and the yolk sac during fetal development. Antibodies targeting AFP have proven valuable in identifying hepatocellular carcinomas (HCC) and germ cell tumors, particularly yolk sac tumors.
Description
Purified human alpha-fetoprotein derived from a collection of human umbilical cord serum.
Physical Appearance
A transparent solution that has undergone sterile filtration.
Formulation
This solution contains AFP protein that has been filtered through a 0.2µm filter. It is prepared in Tris-buffered saline with a pH of 7.5 and contains less than 0.1% sodium azide (NaN3).
Stability
To maintain its stability, Human Alpha-Fetoprotein should be stored at a temperature range of 2-8°C.
Purity
The purity of this product exceeds 95%.
Synonyms
Alpha-fetoprotein, Alpha-fetoglobulin, Alpha-1-fetoprotein, AFP, FETA, HPAFP.
Source
Human cord serum.

Q&A

What methodologies are employed in AFP human trafficking detection research?

The Australian Federal Police employs a multi-faceted methodological approach to human trafficking detection research, focusing on both qualitative and quantitative data collection techniques. The primary methodology involves intelligence gathering through their "Look a Little Deeper Program," which trains first responders to identify key indicators of human trafficking and slavery . This approach combines observational data collection with systematic documentation of case characteristics through standardized protocols and reporting mechanisms. The AFP received 294 reports of alleged human trafficking and slavery offenses in the 2021-2022 financial year, representing the highest-ever recorded number and an increase from 224 in the previous financial year . This quantitative trend analysis forms a crucial component of their research methodology, enabling the identification of emerging patterns and the evaluation of detection strategies.

The methodological framework also incorporates victim-centered interview techniques specifically designed for vulnerable persons, acknowledging the unique challenges in obtaining reliable data from traumatized individuals . Researchers and investigators utilize specialized interview protocols that minimize re-traumatization while maximizing information quality. Analytical methods include network analysis to map trafficking operations, statistical analysis of trafficking patterns, and qualitative coding of victim testimonies to identify common exploitation mechanisms. These methodologies are continuously refined through international collaboration and knowledge exchange with partner law enforcement agencies, creating a dynamic research approach that evolves with the changing nature of human trafficking operations.

How does the AFP Research Innovation Challenge support human trafficking research?

The AFP Research Innovation Challenge represents a structured methodological approach to fostering innovative research on complex law enforcement challenges, including human trafficking. This program creates a collaborative framework between academic researchers and law enforcement practitioners, enabling access to real-world data and operational insights typically unavailable to university-based researchers . Selected student researchers receive the opportunity to engage with the AFP for up to 12 months, during which they can develop and implement their research projects under professional guidance from law enforcement specialists . This collaborative model addresses a fundamental methodological challenge in human trafficking research—the gap between theoretical academic approaches and practical operational realities.

The research methodology supported by this program follows a rigorous ethical approval process, which is a prerequisite before the AFP agrees to be involved with any student researcher . This ensures that all human trafficking research meets appropriate ethical standards, particularly important when working with vulnerable populations or sensitive data. The intellectual property arrangements structured within the program facilitate knowledge transfer between academic institutions and law enforcement, creating pathways for research findings to directly inform operational strategies . While the specific research projects are determined based on current priorities, the program has potential applications in developing new methodologies for victim identification, trafficking network analysis, and evidence collection in human trafficking cases.

What ethical considerations are essential when designing research protocols involving human trafficking victims?

Designing ethically sound research protocols for studies involving human trafficking victims requires methodological approaches that prioritize victim welfare while maintaining research integrity. The primary consideration involves obtaining truly informed consent, which presents unique challenges when working with individuals who may have experienced psychological trauma, language barriers, or fear of authorities . Methodologically, this requires the development of trauma-informed consent processes that account for power differentials between researchers and participants, often involving trained interpreters and psychological support personnel during the consent and data collection process. The AFP's approach emphasizes that victims may not self-identify as victims according to Australian law, necessitating specialized methodological frameworks that account for varying cultural understandings of exploitation .

Data security and confidentiality present additional methodological considerations, requiring specialized protocols for anonymizing and securely storing sensitive information that could potentially endanger victims if disclosed. Research designs must incorporate robust data protection measures beyond standard academic practices, often including encoding systems that separate identifying information from research data. The involvement of support services represents another critical methodological component, with the AFP's practice of referring victims to the Australian Government Support for Trafficked People Program serving as a model for ethical research practice . This integrated approach ensures that research participation does not occur in isolation from support services, allowing for immediate intervention if the research process reveals ongoing risks or unmet needs.

What advanced data analysis techniques are demonstrating efficacy in identifying patterns in human trafficking networks?

Advanced computational methodologies are increasingly central to identifying complex patterns in human trafficking networks, with the AFP employing sophisticated intelligence-driven approaches to detect criminal operations. Social network analysis (SNA) has emerged as a particularly valuable methodology, allowing researchers to map relationships between traffickers, victims, facilitators, and consumers of exploitative services . This technique involves constructing mathematical models of network structures based on communications data, financial transactions, and known associations, enabling the identification of key nodes and vulnerabilities within trafficking operations. The methodological approach integrates data from multiple sources, including telecommunications records, financial intelligence, migration patterns, and victim testimonies, requiring specialized data integration protocols to maintain data integrity across diverse information systems.

Machine learning algorithms represent another advanced methodological frontier, with supervised learning approaches being trained on historical case data to identify high-risk scenarios and predict trafficking activities . The methodological challenge in this approach involves creating appropriate training datasets that capture the diversity of trafficking operations while avoiding algorithmic bias that might miss emerging trafficking methods. The AFP's strategic approach includes "harnessing intelligence including the development of intelligence products to increase understanding of the size and changing nature of the human trafficking and slavery threat" , indicating a methodological commitment to adaptive analytical frameworks. Cross-border data sharing methodologies present particular challenges, requiring standardized protocols for information exchange that comply with varying national privacy regulations while enabling timely analysis of transnational trafficking operations.

How can researchers address the methodological challenges in measuring the prevalence and impact of modern slavery?

Methodological challenges in quantifying modern slavery stem from its clandestine nature, definitional ambiguities, and barriers to victim identification, requiring innovative research approaches. The hidden population sampling methodology represents one advanced approach, employing techniques such as respondent-driven sampling, capture-recapture methods, and multiple systems estimation to generate prevalence estimates from limited observable data . These methodologies require careful validation procedures to account for selection bias and non-random access to trafficking victims. Longitudinal research designs present another methodological approach to understanding trafficking trajectories and intervention outcomes, though these face significant challenges in maintaining contact with highly mobile or hidden populations over extended timeframes.

Interdisciplinary triangulation methodology offers a promising approach to addressing measurement validity concerns, combining qualitative victim interviews, quantitative pattern analysis, and economic labor market assessments to create more robust prevalence estimates . The AFP's strategic commitment to "increasing our understanding of the nature and extent of human trafficking and slavery" reflects recognition of these methodological challenges. Mixed-methods approaches that integrate law enforcement data with health service encounters, labor inspections, and community outreach reports can help overcome single-source limitations. These methodological innovations are essential given the AFP's observation that many victims "are not aware they are victims according to Australian law" , requiring measurement approaches that can capture exploitation across varying cultural and legal frameworks.

What interdisciplinary research methodologies show promise in evaluating human trafficking prevention strategies?

Evaluating the effectiveness of human trafficking prevention strategies requires sophisticated interdisciplinary methodologies that can measure both implemented activities and their actual impact on trafficking prevalence. Contribution analysis methodology offers one promising approach, allowing researchers to evaluate prevention initiatives in complex environments where direct causality is difficult to establish . This methodological framework involves creating detailed theories of change for prevention strategies, then systematically gathering evidence to assess whether and how interventions contribute to observed outcomes. The AFP's prevention objective focuses on "opportunities to prevent human trafficking and slavery offences by focusing on the root causes of exploitation, raising awareness and building the resilience of groups who may be vulnerable to these practices" , necessitating evaluation methodologies that can assess changes in both vulnerability factors and exploitation outcomes.

Quasi-experimental research designs represent another advanced methodological approach, comparing regions or communities where prevention initiatives have been implemented with similar contexts lacking such interventions. These methodologies require careful matching procedures to ensure comparability between intervention and control sites, along with robust measurement protocols to assess trafficking vulnerability and incidence. Participatory evaluation methodologies show particular promise for assessing community-based prevention, involving at-risk populations in defining relevant outcome measures and collecting data on prevention effectiveness . The AFP's strategy of "working collaboratively with government, NGOs and industry" and "fostering interdisciplinary research collaboration, including through the Human Trafficking and Modern Slavery Research Network" indicates recognition that methodologically sound prevention evaluation requires diverse expertise and stakeholder involvement.

What are the primary laboratory techniques for isolating and analyzing human AFP?

Human Alpha-Fetoprotein (AFP) isolation and analysis employ several standardized methodological approaches that form the foundation of research in this field. Recombinant expression systems represent a primary methodology for producing research-grade human AFP, with both bacterial (E. coli) and yeast expression systems having demonstrated successful production of functional recombinant human AFP (rhAFP) . These expression systems require careful optimization of growth conditions, induction parameters, and purification protocols to maintain protein functionality. Following expression, affinity chromatography combined with size exclusion chromatography constitutes the methodological basis for purifying rhAFP to the high standards required for research applications, typically achieving >95% purity as verified by SDS-PAGE analysis.

Enzyme-linked immunosorbent assay (ELISA) serves as the gold standard methodology for quantitative analysis of human AFP in research and clinical samples, offering high sensitivity and specificity . The sandwich ELISA technique, which employs two antibodies targeting different epitopes on the AFP molecule, provides particularly reliable quantification with detection limits in the nanogram range. Western blotting methodology complements ELISA by enabling analysis of AFP integrity, potential degradation products, and post-translational modifications through size-based separation followed by immunodetection. Functional analysis of AFP binding properties typically employs methodologies such as fluorescence polarization assays or surface plasmon resonance, which can quantify the binding kinetics between AFP and various ligands including fatty acids, retinoids, steroids, and experimental drug compounds .

How does recombinant human AFP differ from native human AFP in research applications?

Recombinant human Alpha-Fetoprotein (rhAFP) and native human AFP demonstrate important methodological distinctions in research applications that must be considered when designing experiments. The expression system methodology significantly influences rhAFP properties, with bacterial systems producing non-glycosylated protein while eukaryotic systems (such as yeast) can produce partially glycosylated variants . Research has established that these recombinant AFPs have "biological properties related, but not identical to native human AFPs" , necessitating careful characterization of each preparation before experimental use. Methodologically, this characterization typically involves comparative binding assays, circular dichroism spectroscopy to assess secondary structure, and functional assays specific to the research application.

The ligand-binding methodology for rhAFP research requires particular attention to experimental conditions, as binding affinity for various ligands may differ between recombinant and native forms. Studies have demonstrated that rhAFP maintains the ability to "bind and transport a multitude of ligands such as bilirubin, fatty acids, retinoids, steroids, hormones, flavonoids, phytoestrogens, heavy metals, dioxins and various organic drugs" , though binding constants may vary from native AFP. Cell receptor interaction methodologies constitute another area requiring careful consideration, as rhAFP interaction with AFP receptors (AFPRs) on target cells may display altered kinetics compared to native protein . Research protocols typically address these differences through side-by-side comparative experiments or by establishing standardized correction factors based on empirical data comparing recombinant and native forms.

What methodological considerations are important when using human AFP as a cancer biomarker?

Using human Alpha-Fetoprotein as a cancer biomarker involves several methodological considerations that influence experimental design and clinical application. Sample collection and processing methodology significantly impact AFP measurement, requiring standardized protocols for timing, handling, and storage of samples to maintain reproducibility across research studies. Serum AFP levels exhibit biological variability influenced by factors including age, sex, pregnancy status, and certain non-malignant conditions, necessitating careful selection of appropriate reference ranges and control populations when designing research protocols . Statistical methodologies for establishing clinical thresholds require particular attention, often employing receiver operating characteristic (ROC) curve analysis to optimize sensitivity and specificity for specific cancer types.

Methodological approaches to AFP isoform analysis have demonstrated research value beyond simple concentration measurements, as distinct glycoform patterns have been associated with different pathological conditions. Research protocols increasingly incorporate methodologies such as lectin affinity electrophoresis or mass spectrometry to characterize AFP isoforms, providing enhanced specificity for cancer detection. Multimarker panel methodology represents another important consideration, with research indicating that combining AFP with other biomarkers can enhance diagnostic accuracy . The sandwich ELISA technique employed in many studies, such as those measuring carcinoembryonic antigen (CEA) and prostate-specific antigen (PSA) alongside AFP, requires careful validation to ensure non-interference between assays when performed on the same sample .

What methodological approaches optimize the drug-carrying capacity of recombinant human AFP?

Optimizing the drug-carrying capacity of recombinant human Alpha-Fetoprotein (rhAFP) involves sophisticated methodological approaches focusing on binding site engineering and complex formation parameters. Structural biology methodologies, including X-ray crystallography and molecular dynamics simulations, have enabled precise mapping of drug-binding domains and informed rational design of rhAFP variants with enhanced carrying capacity for specific therapeutic compounds . The research on 1′-S-1′-acetoxychavicol acetate (ACA) complexed with rhAFP demonstrates a methodological template for optimizing drug delivery, where the systematic investigation of binding kinetics, complex stability, and release parameters enabled the development of an effective delivery system for this poorly soluble anti-cancer compound . This methodology involves iterative binding experiments under varying pH, temperature, and ionic strength conditions to identify optimal complex formation parameters.

Analytical ultracentrifugation combined with fluorescence spectroscopy provides a methodological approach for quantifying drug loading capacity and heterogeneity in rhAFP-drug complexes. These techniques enable researchers to determine the stoichiometry of binding and identify potential cooperative effects that influence carrying capacity. The methodology for addressing "poor in vivo solubility, depreciation of biological activity upon exposure to an aqueous environment and non-specific targeting of tumour cells" involves systematic formation and characterization of non-covalent complexes under controlled conditions. Research has validated that rhAFP "acts as a non-covalent carrier for various active apoptosis-inducing water-insoluble ingredients aimed at cells expressing AFP receptors (AFPRs)" , with the specific methodology involving pre-formation of complexes under optimized conditions followed by stability testing under physiological conditions.

How can researchers address the variability in AFP receptor expression across different tumor types?

Methodological approaches to addressing AFP receptor (AFPR) variability across tumor types involve quantitative receptor profiling, correlation analysis, and targeted delivery optimization techniques. Immunofluorescence-immunocytochemistry (IF-IC) methodology, as employed in studies examining the correlation between drug efficacy and AFPR expression, provides quantitative assessment of receptor density and distribution on tumor cells . This technique enables researchers to develop standardized receptor expression profiles across tumor types, facilitating prediction of likely response to AFP-mediated drug delivery. The methodological approach incorporates both surface receptor quantification and analysis of internalization kinetics, as efficacy depends not only on initial binding but also on subsequent cellular processing of the AFP-drug complex.

Correlation analysis methodology employing Pearson's correlation or similar statistical approaches enables researchers to establish quantitative relationships between receptor expression levels and therapeutic responses . This methodological framework supports rational selection of tumor types for AFP-targeted therapy and informs dosing strategies based on expected receptor density. Flow cytometry sorting methodology provides a complementary approach, enabling enrichment of receptor-positive populations for detailed mechanistic studies of AFP-drug complex processing. The experimental design typically includes comparative analysis across multiple tumor types with varying AFPR expression levels, controlled for other variables that might influence drug sensitivity.

What are the latest techniques for enhancing the specificity of AFP-based drug delivery systems?

Advanced methodological approaches to enhancing AFP-based drug delivery specificity focus on molecular engineering, combination targeting strategies, and optimized formulation techniques. Site-directed mutagenesis methodology enables selective modification of AFP binding properties, creating variants with enhanced affinity for tumor-associated receptors while reducing interaction with receptors on healthy tissues . This approach requires precise mapping of receptor-binding domains followed by systematic alteration of key residues to optimize the affinity differential between target and non-target tissues. The experimental validation methodology typically involves comparative binding studies using both engineered and wild-type AFP across multiple cell types, quantifying specificity enhancement through binding ratio calculations.

Synergistic delivery system methodology, as demonstrated in research combining rhAFP with anti-cancer compounds like 1′-S-1′-acetoxychavicol acetate (ACA), represents another approach to enhancing specificity . This methodology exploits the observation that AFP "could be seen as a death factor, highly selective against tumour cells but completely non-toxic to normal cells" by creating drug complexes that require both AFP receptor binding and tumor-specific microenvironmental conditions for drug release. The experimental approach involves systematic testing of drug release under varying pH, enzymatic, and redox conditions that simulate tumor versus normal tissue environments. Pharmacokinetic profiling methodology using labeled AFP variants enables quantitative assessment of tissue distribution and clearance patterns, providing critical data for optimizing dosing regimens to maximize tumor exposure while minimizing accumulation in healthy tissues.

How can computational modeling enhance both AFP oncology research and human trafficking pattern detection?

Computational modeling methodologies offer powerful approaches to addressing complex research challenges in both AFP oncology research and human trafficking pattern detection, despite their apparent domain differences. In AFP oncology research, molecular dynamics simulation methodology enables detailed modeling of AFP-drug interactions and binding site dynamics, predicting how structural modifications might alter drug carrying capacity or receptor specificity . These simulations typically employ force field parameters optimized for protein-ligand interactions, running on high-performance computing clusters to achieve the microsecond timescales needed for meaningful binding analysis. The methodological approach involves systematic validation against experimental binding data, with iterative refinement of simulation parameters to improve predictive accuracy for novel drug candidates.

For human trafficking pattern detection, machine learning methodologies employing neural networks and natural language processing can identify subtle patterns in unstructured data that might indicate trafficking operations . The methodological framework involves training algorithms on known trafficking cases, then applying them to diverse data sources including online advertisements, financial transactions, and travel records to identify high-risk patterns. Both research domains benefit from network analysis methodology, though applied differently—in oncology research for analyzing protein interaction networks that might influence AFP function, and in trafficking research for mapping criminal organization structures and operational patterns . The computational approaches share core methodological elements including data preprocessing, feature extraction, model validation, and interpretation of complex multidimensional results.

What methodological frameworks support translating laboratory findings on AFP into clinical applications?

Translational research methodologies bridge the gap between laboratory discoveries regarding Alpha-Fetoprotein and clinical applications, providing structured frameworks for moving from bench to bedside. The phased translational pipeline methodology begins with in vitro validation of AFP-drug complexes, progresses through animal models, and ultimately advances to early-phase clinical trials, with specific methodological considerations at each stage . The in vitro methodology typically employs multiple cell line models with varying AFP receptor expression levels, enabling assessment of specificity and potential off-target effects before advancing to more complex systems. Animal model methodology requires careful selection of appropriate models that recapitulate relevant aspects of human cancer, often using patient-derived xenografts in immunocompromised mice as demonstrated in studies using "athymic nude (Nu/Nu) mice... treated with various combination regimes intraperitoneally" .

Biomarker development methodology constitutes another critical translational approach, correlating AFP levels or AFP-receptor expression with clinical outcomes to identify patient populations most likely to benefit from AFP-based therapies. This methodological framework typically includes retrospective analysis of biomarker status in tissue banks with known outcomes, followed by prospective validation in clinical cohorts. The translational methodology also addresses manufacturing and quality control challenges in moving from laboratory-scale production to clinical-grade materials, requiring development of scalable production methods that maintain consistent biological activity. The concept validated in AFP research of "developing drug conjugates or complexes to optimize patients' tolerance and increasing the anti-tumour efficiency of common chemotherapeutic drugs via directed delivery of cytotoxic agents towards the target cells using protein molecules" provides a methodological template applicable to other protein-based delivery systems.

How can ethical research frameworks from human trafficking studies inform consent processes in vulnerable patient populations for AFP clinical trials?

Ethical research methodologies developed for human trafficking studies offer valuable frameworks for addressing similar vulnerabilities in clinical trial populations, particularly for AFP-based therapies targeting advanced cancer patients. The trauma-informed consent methodology employed in human trafficking research, which acknowledges and accommodates the impact of previous traumatic experiences on the consent process , has direct applicability to oncology trials involving patients who may be experiencing psychological distress following cancer diagnosis and previous treatment failures. This methodological approach involves phased consent processes, simplified information presentation, and ongoing verification of understanding and voluntary participation throughout the research process. The specific techniques developed for interviewing vulnerable trafficking victims, including specialized training for investigators , can inform similar training programs for clinical researchers working with seriously ill patients.

Cultural competence methodology from trafficking research, which recognizes that "victims may not be aware they are victims according to Australian law... language barriers may limit their ability to report" , translates directly to international clinical trials where varying cultural understandings of medical research and treatment may influence the consent process. This methodological framework involves culturally tailored information materials, trained cultural mediators, and flexibility in communication approaches based on cultural background. The support integration methodology employed in trafficking research, where victims are immediately connected with the "Australian Government Support for Trafficked People Program" , offers a model for integrating supportive care services with clinical trials, ensuring that research participants have access to comprehensive support regardless of trial outcomes. Both research domains benefit from methodological approaches that balance scientific rigor with protection of vulnerable individuals, recognizing that valid research requires truly informed participation.

Product Science Overview

Production and Structure

AFP is primarily produced by the yolk sac and the fetal liver during fetal development . It is a glycoprotein composed of 591 amino acids and includes a carbohydrate moiety . AFP is found in monomeric, dimeric, and trimeric forms .

Function

The exact function of AFP in adult humans remains unknown. However, in the fetus, AFP is believed to function similarly to serum albumin, acting as a carrier protein that transports materials such as fatty acids to cells . AFP binds to various substances, including copper, nickel, fatty acids, and bilirubin .

Clinical Significance

AFP is a significant biomarker in clinical settings. Maternal serum levels of AFP are used to screen for Down syndrome, neural tube defects, and other chromosomal abnormalities . Elevated levels of AFP in adults are often associated with hepatocellular carcinoma (HCC) and teratomas . Up to 70% of HCC patients exhibit elevated serum levels of AFP .

Role in Hepatocellular Carcinoma (HCC)

AFP is not only a diagnostic marker for HCC but also plays a complex role in the disease’s progression. It is involved in regulating cell proliferation, apoptosis, autophagy, and immune response inhibition . High serum levels of AFP usually indicate a high risk of HCC development and a poor prognosis .

Expression Patterns

In the fetus, AFP is produced by both the liver and the yolk sac. Maternal plasma levels peak near the end of the first trimester and begin decreasing prenatally, reaching normal adult levels by the age of 8 to 12 months . In adults, AFP expression is typically low but can be aberrantly expressed in liver cancer cells .

Research and Future Directions

Ongoing research aims to further understand the role of AFP in the development of HCC and its potential as a therapeutic target. Exploring the biological functions of AFP may lead to new treatments for liver cancer and other related conditions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.